Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.200
-0.030 (-2.44%)
Sep 28, 2026, 2:40 PM EDT - Market open
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $69.88 million as of September 28, 2026. Its market cap has decreased by -34.32% in one year.
Market Cap
69.88M
Enterprise Value
21.15M
1-Year Change
-34.32%
Ranking
Category
Stock Price
$1.20
ChartMarket Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $69.88M, a decrease of -54.65%. That is a compound annual growth rate of -8.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 69.88M | -46.78% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortress Biotech | 76.04M |
| Verrica Pharmaceuticals | 75.07M |
| RenovoRx | 74.91M |
| BioStem Technologies | 73.90M |
| MAIA Biotechnology | 72.99M |
| Aldeyra Therapeutics | 72.69M |
| OKYO Pharma | 72.42M |
| Cingulate | 70.24M |